Vaishali Pharma allots shares to Kesar Pharma via share swap

Fund Raising View source PDF Explain this filing

VAISHALI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.7%Reaction day

₹7.30

prior close

₹7.57

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+2.5% vs market

Pharmaceuticals peers, median of 164sector-0.5%+3.3% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 3.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.6

10m

-3.6

15m

-2.9

30m

-2.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.7+0.2+2.5-0.5+3.3

Next day

+1.9-0.5+2.4-0.7+2.6

-0.8-2.5+1.7-1.7+0.9

-1.4-0.6-0.7-1.2-0.1

+3.6+0.7+2.8-0.5+4.0

+8.6+0.9+7.8+0.2+8.4

+7.5+0.5+7.0+0.4+7.1

15d

+6.0-0.2+6.3-1.4+7.5

+8.2+2.9+5.3-1.7+9.9

+14.9+5.0+10.0+1.2+13.7

+12.7+3.7+9.0+0.4+12.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vaishali Pharma has allotted 45,37,865 equity shares at Rs. 20 each, totalling about Rs. 9.08 crore, to Kesar Pharma Limited on a preferential basis. The shares were issued for non-cash consideration as part of acquiring a 26.95 percent stake in Kesar Pharma. After the allotment, Kesar Pharma holds 3.36 percent of Vaishali Pharma's expanded equity. Paid-up capital has risen from Rs. 26.09 crore to Rs. 27 crore, with total shares now at 13.49 crore.

Likely market impact

Share swap for KPL acquisition causes about 3.36 percent equity dilution but brings a strategic partner with no cash outflow for the company.